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Abstract
Currently, spectral domain optical coherence tomography (SD-OCT) is a basic tool in 
diagnosing and monitoring diabetic macular edema (DME), which is the most frequent 
cause of visual impairment in the diabetic patients. OCT technology has changed the 
classification of DME from the traditional criteria. Macular thickness measured on 
OCT is considered an outcome measure to evaluate the structural and functional out-
come of various therapeutic means used in DME. SD-OCT evaluates ultrastructural 
retinal parameters, such as the ellipsoid zone, photoreceptor outer segment length and 
quantifies the individual layers according to various algorithms. The aim is to present 
the way in which SD-OCT technology has changed our clinical practice during the last 
years, in diagnosing, classifying and treating DME and to illustrate its impact with 
practical cases.
Keywords: spectral domain-optical coherence tomography, diabetic macular edema, 
macular thickness, macular traction
1. Introduction
Currently, there are 400 million diabetics in the world and according to World Health 
Organization, by the year 2030 the population of diabetics will double [1, 2]. Diabetic reti-
nopathy (DR) is the main cause of visual impairment within the working age population 
group [1, 2]. Quality of life is affected even if visual acuity decrease is mild/moderate. In the 
context of DR, diabetic macular edema (DME) is the most common cause of visual impair-
ment, especially in type 2 diabetes. It is estimated that one out of four diabetics develops DME 
over a lifetime [1, 2].
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OCT represented a breakthrough in the management of DME, both for its diagnosis and 
monitoring of treatment effects. OCT technology offers valuable quantitative data (macular 
thickness, extension of edema, macular volume) and qualitative ones (macular morphology, 
vitreo-macular interface) [3].
The advantages of OCT over other imaging modalities are as follows: its noninvasiveness, 
rapidity and safety profile [3, 4].
2. Theoretical consideration on OCT
The principle of tomography consists in the reconstruction of cross-sectional images of an 
object using its projections. The concept of OCT developed in 1990 and the first commercial 
version of OCT belongs to Carl-Zeiss in 1996. The first clinical application of OCT technology 
was in the field of ophthalmology. The obtained images reveal the optical properties of the 
scanned tissues and not the tissues themselves, and they are very similar to the histological 
sections.
There are two OCT methods: time domain (TD-OCT) and spectral domain (SD-OCT). The 
properties of the two methods are synthesized in Table 1 [3, 4].
The most common application of OCT is the measure of macular thickness. With TD-OCT, 
macular thickness map is calculated from six radial scans crossing at the fovea from which 
result the medium macular thickness and the total macular volume. With SD-OCT, image 
resolution is significantly higher. Different landmarks are used to calculate macular thick-
ness with TD-OCT and SD-OCT. With TD-OCT, photoreceptors external segments are not 
differentiated from the retinal pigmented epithelium (RPE) and are therefore excluded from 
Property TD-OCT SD-OCT
Principle Low-coherence interferometry Fourier equation
Acquisition An interferometer evaluates sequentially the 
back scattering of the light by the retinal 
structures
A spectrometer evaluates simultaneously the back 
scattering of the light by the retinal structures
Sampling Point by point All points simultaneously
Acquisition time 1–2 s 60 times faster
Target area Six radial scans 20 μm wide and 6 mm long Φ 6 mm = 65,000 scans
Acquisition rate 400 scans/s 25,000–52,000 scans/s
Display 2D 3D
Axial resolution 10–15 μ 3–7 μ
Table 1. Properties of TD-OCT and SD-OCT.
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the evaluation of macular thickness. SD-OCT allows photoreceptors external segments be 
differentiated from the retinal pigmented epithelium (RPE)  and are included in the value of 
the macular thickness [3, 4].
Many SD-OCT devices are used in the clinical practice. Their axial resolutions and scanning 
speeds are presented in Table 2.
OCT and ultrasounds are complementary methods in assessing the vitreo-retinal interface. 
Ultrasound scans provide a more complete image of the vitreo-retinal interface, but with sig-
nificantly lower resolution. OCT offers a high resolution image of a limited area. Since OCT 
uses light to acquire images, its use is limited by media opacities [5, 6].
OCT is a noninvasive, well-tolerated method, easy to understand and explain. It offers quali-
tative information on retinal thickness, and it is reliable and reproducible. OCT reveals the 
presence and extension of vitreo-macular traction (VMT) [5, 6].
OCT technology holds the promise for the unprecedented capability to describe and monitor 
the changes in retina geometry.
3. Normal OCT aspect of the macula
The normal retinal layers have different reflectivity on OCT scans. Thus, the nerve fibers 
and the retinal pigmented epithelium (RPE) display high reflectivity, the plexiform and the 
nuclear layers have intermediate reflectivity and the photoreceptors display low reflectivity 
[3, 4]. The most commonly scan algorithms used in the clinical practice are the line and the 
volume (cube). Retinal thickness is automatically measured by the use of device software. The 
Device (company) Axial resolution (μ) Scans/s
Cirrus HD-OCT (Carl Zeiss Meditec) 5 27,000
Spectralis (Heidelberg Engineering) 7 40,000
RE Vue (Optovue) 5 26,000
3D OCT-1000
3D OCT-2000 (Topcon)
6 18,000
Spectral OCT/SLO (OPKO/OTI) 5 27,000
SOCT Copernicus (Optopol) 6 25,000
SOCT Copernicus HR (Canon/Optopol Inc.) 3 50,000
SD-OCT (Bioptigen) 4 20,000
Retinascans RS 3000 (Nidek) 7 53,000
Table 2. SD-OCT devices used in ophthalmology.
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distance between the vitreo-retinal interface and the anterior surface of the RPE is generally 
comprised between 200 and 275 μm; the foveal depression ranges from 170 to 190 μm and the 
thickness of the peripheral retina is between 220 and 280 μm [5].
4. Macular edema
Macular edema is the main pathologic feature of diabetic maculopathy. According to ETDRS, 
it is defined as any detectable retinal thickening due to fluid accumulation. It may be local-
ized in a sector of the macular region (focal) or it may be diffused. Persistent macular edema 
leads to the necrosis of Muller cells with subsequent formation of cystoid cavities localized 
mainly in the outer retinal layers (Henle’s fiber, external plexiform) and sometimes in the 
inner plexiform layer too. In more advanced stages, the cavities may coalesce centrally form-
ing a large hyporeflective cavity that accounts for the significant increase of foveal thickness. 
By consequence, beside increase of macular thickness (which is the most important OCT 
sign) in DME appear: large intraretinal spaces of reduced reflectivity, loss of the normal 
layered retinal structure and flattening of the central foveal depression. Sometimes fluid 
can be seen under the neurosensory retina. Hard exudates and hemorrhages are typical 
landmarks for DR and they appear on OCT images as small hyperreflective deposits with 
posterior shadowing [6].
The cysts that develop in the retina during DME vary in size. According to their size, a classi-
fication of cystoid edema was proposed by Koleva-Georgieva into mild, moderate and severe. 
In mild edema, cysts are small and predominantly located in the outer retinal layers. In the 
intermediate and severe forms, cysts are located in the outer layers, especially in the fovea. 
If cysts continue to increase, they occupy the whole thickness of the retina, leading to macu-
lar atrophy and profound visual loss. In mild edema, the cysts have a horizontal diameter 
below 300 μm, in intermediate edema the horizontal diameter of the cysts is between 300 and 
600 μm and in the severe one the horizontal diameter of the cysts is above 600 μm or large 
confluent cavities with retinoschisis appearance are identified [6–8].
It has been shown that the status of the outer retinal layers is important for the visual out-
come in patients with DME. Yohannan et al. proved that disruption of the IS/OS junction 
correlates well with a significant decrease of point sensitivity in patients with DME. Also, 
the integrity of ELM and IS/OS junctions correlates positively with visual acuity. Therefore, 
OCT evaluation of the outer retinal layers in patients with DME is important in predicting 
visual outcome [6].
Vitreo-retinal interface is very important in diabetic patients. It is known that diabetics have 
higher than normal vitreo-retinal adherence and that vitreo-macular traction is one of the fac-
tors explaining DME. OCT identifies various aspects: incomplete posterior vitreous detach-
ment (PVD), epiretinal membranes (ERM) [6, 7]. OCT identifies vitreo-macular interface 
disorders from the preclinical stage. If posterior hyaloid is thin and partly detached from the 
macula, this aspect cannot be seen on biomicroscopy, but it is easily detectable on OCT. The 
same is true regarding the thin ERM. Thus, OCT is a very useful tool that establishes the best 
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therapeutic option in these cases: vitrectomy with release of vitreo-macular traction/dissection 
of ERM, from the early stages, when the chances for a good functional outcome are the highest. 
Assessment of vitreo-macular interface is an important step in evaluating diabetic patients. Not 
only does OCT indicate the moment for vitrectomy in these patients, but it also monitors the 
postoperative morphological outcomes: favorable evolution (decrease of macular thickness), 
development of ERM or of lamellar macular hole [6].
The detached posterior vitreous face appears on OCT scans as a thin horizontal or oblique line 
with low/medium reflectivity in the nonreflective vitreous, above or inserting into the retina. 
If PVD is incomplete, it may adhere to the foveal or peripapillary region. ERM appears on 
OCT as a hyperreflective line on the surface of the retina. Its presence leads to retinal modi-
fications: increase of macular thickness, loss of foveal depression, formation of intraretinal 
cysts and pseudoholes. The difference between PVD and ERM is made according to their 
reflectivity (low in PVD, high in ERM). OCT provides other details related to ERM (degree of 
opacity, thickness, and distance from the macula) and to its effects on the underlying retina: 
distortion, edema, neurosensory detachment [6].
OCT is a very reliable and reproducible method to assess and monitor macular thickness fol-
lowing various treatments for DME: intravitreal injections with anti-VEGF and steroids, laser 
photocoagulation, vitrectomy. OCT also identifies macular atrophy which explains functional 
failure despite resolution of edema. Monitoring patients with DME must include two major 
parameters: functional (visual acuity) and anatomical (OCT) [5, 6].
Cystoid macular edema (CME) appears like large ovoid spaces of low reflectivity separated by 
hyperreflective septae that represent intraretinal cystoid-like cavities. Posterior hyaloid traction 
(PHT) appears like a highly reflective band on the surface of the retina. Serous retinal detach-
ment (SRD) appears as a dark accumulation of subretinal fluid beneath the high reflective and 
dome-like elevation of detached retina. The highly reflective band which represents the outer 
surface of the retina helps differentiating subretinal fluid from the intraretinal fluid. Tractional 
retinal detachment (TRD) is identified as the area of low signal underlying the highly reflective 
border of detached retina. It often takes the appearance of a pick-shaped configuration [5, 6].
The most common finding in diabetics is diffuse retinal thickening (DRT) [6].
There is a correlation between macular thickness and visual acuity in patients with DME. The 
OCT pattern that was associated with worse visual outcome is CME [6].
In DME OCT technology has significant impact at various levels: it elucidates the pathogenic 
mechanisms of DME; it has a major contribution in identifying hyaloid-macular traction; it 
identifies the subclinical DME allowing early treatment; it makes it possible to correlate mac-
ular thickness with visual acuity; it monitors the evolution of DME following treatment [5–7].
5. OCT classification of macular edema
Along with the development of OCT imaging, various classifications of DME have been elab-
orated. The first OCT classification of DME belongs to Otani, and it is based on morphological 
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parameters, into three categories: sponge-like swelling, cystoid edema and serous retinal 
detachment [5]. A fourth category was added by Trichonas et al., posterior hyaloid trac-
tion (PHT) [6]. A more detailed classification was proposed by Koleva-Georgieva, and it is 
based on quantitative and qualitative OCT data: retinal thickness, retinal morphology, retinal 
topography, macular traction, foveal photoreceptor status (Table 3) [8].
6. OCT-angiography
OCT-Angiography (OCT-A) enables the noninvasive visualization of 3D retinal capillary 
network. It correlates very well with fluorescein angiography (FA), and it is able to show 
even more capillaries in the pericentral macula than FA and to separate and individualize the 
superficial and deep capillary plexus.
7. Personal experience with SD-OCT in DME
The personal experience in using SD-OCT for the management of DME is illustrated by sev-
eral cases (Figures 1–8).
In this case, the OCT aspect of the macula favored intravitreal injection of anti-VEGF in AO, 
given the absence of PHT and the high amount of fluid within the retina OS. In OD, early 
Retinal thickness No macular edema Normal macular thickness
Early subclinical ME Macular thickening nondetectable clinically
Retinal thickness increased on OCT
Established ME Retinal thickening and morphological signs of edema
Retinal morphology Simple noncystoid ME Increased retinal thickness; reduced retinal reflectivity; 
irregularities of the layered retinal structure; flattening of the 
foveal depression; no cystoid spaces
Cystoid ME Well-defined intraretinal cystoids spaces
Serous macular 
detachment
Hyporeflective area under the detached neurosensory retina and 
over the hyperreflective line of EPR
Vitreo-macular 
interface
No MT Complete PVD/no PVD/no ERM
Questionable MT Incomplete PVD with no detectable distortion of retinal surface 
contour at the point of adhesion
Definite MT Incomplete PVD with distortion of retinal surface contour at the 
point of adhesion
Retinal outer layers IS/OS and ELM intact IS/OS and ELM intact
IS/OS and ELM with 
disrupted integrity
IS/OS and ELM with disrupted integrity
Table 3. OCT classification of macular edema (after Koleva-Georgieva).
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treatment in the stage of mild edema had positive outcome. In OS, the high degree of macular 
disorganization prevented a significant improvement in vision (Figure 2).
In this case, intravitreal anti-VEGF injections alone would probably not lead to the resolution 
of edema, because vitreo-macular traction is also involved in its pathophysiology. Therefore, 
pars plana vitrectomy with dissection of the posterior hyaloid from the macular area was 
indicated (Figures 3 and 4).
In this case, anti-VEGF injections are indicated in AO, but with a much better prognosis in 
LE where edema is mild, as compared to RE in which the macula is disorganized (Figures 5 
and 6).
In this case, beside anti-VEGF injections, pars plana vitrectomy appears reasonable in order to 
release the traction exerted by the posterior hyaloid on the macula.
Even if macular edema is mild, intravitreal anti-VEGF would prevent its progression toward 
more advanced stages with cystoid degeneration of the macula (Figure 7).
On the ground of the OCT aspect, intravitreal anti-VEGF injections are indicated in OD, but 
not in LE in which retinal atrophy is present (Figure 8).
Figure 1. OD diffuse mild thickening of the macular region. OS large ovoid spaces of low reflectivity (liquid content) 
separated by hyperreflective septae located in the neurosensitive retina that represent intraretinal cystoid-like cavities; 
hyperreflective deposits with posterior shadowing (hard exudates, hemorrhages) in the neurosensory retina; no 
evidence of PHT; significant increase of the macular thickness, mainly centrally—on the account of the cystoids cavities.
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Figure 3. Diffuse DME in AO in a young patient with type 1 diabetes. Fluid is present within the neurosensitive retina 
in the fovea (dark spaces). PHT is not present; therefore, intravitreal anti-VEGF injections were indicated with good 
outcome.
Figure 2. Moderate increase of the macular thickness in a diffuse manner, most likely caused by PHT: posterior hyaloid 
appears as a highly reflective band adherent to the underlying retina.
OCT - Applications in Ophthalmology48
Figure 4. OD marked increase of the macular thickness, large cystoid cavities in the neurosensory retina separated by 
moderately reflective septae; OS slight increase of the macular thickness with diminishing of the foveal profile and 
tendency to flattening of the macular retina (early macular edema).
Figure 5. Focal macular edema OU: OD—beside the cystoid cavities within the neurosensitive retina, PHT is revealed; 
OS—smaller cystoid cavities with hyperreflective deposits and loss of normal foveal contour.
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Figure 6. OD diffuse macular edema with preservation of the foveal contour and hyperreflective deposits in the 
neurosensory retina; OS mild focal macular edema.
Figure 7. OD severe macular edema with considerable thickening of the macular area, cystoid cavities within the retina 
with involvement of the outer retinal layers and disorganization of the retinal pigmented epithelial line, PHT; OS retinal 
atrophy at the level of the foveal region.
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In LE (not vitrectomized) there is a slightly increase in macular thickness related to the trac-
tion of the posterior hyaloid on the macula. In RE, vitrectomy released the vitreo-macular 
traction and macular thickness is almost within the normal range.
8. Importance of OCT in selecting the appropriate therapy for DME
For many years, the only therapy of DME was laser photocoagulation which was indicated 
exclusively on clinical criteria, defined by Early Treatment Diabetic Retinopathy Study 
(ETDRS) as clinically significant macular edema [9]. Currently, therapeutic approaches of 
DME expanded, including anti-VEGF and steroid intravitreal injections and vitreo-retinal 
surgery [9]. The selection of the optimal therapy is correlated with the pathogeny of DME, 
which is best elucidated by OCT.
In most circumstances, DME is the consequence of internal blood-retinal barrier break-down 
with subsequent accumulation of fluid in the retina. Macular thickness and fluid topography 
are precisely evaluated by OCT. In these DME categories, the first line treatment is repre-
sented in our practice by intravitreal anti-VEGF injections. In refractory cases intravitreal 
steroids are considered.
Figure 8. OD aspect following pars plana vitrectomy and dissection of the posterior hyaloid: mild diffuse macular 
edema, with normal foveal profile; OS mild macular edema with reflective posterior hyaloid adherent to the macula.
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OCT is the only method capable to identify and describe the aspect of the vitreoretinal interface. 
As such, within the DME group OCT individualizes a subgroup of patients with posterior hya-
loid traction (PHT) which is often overlooked with fundus biomicroscopy. This particular form 
of DME is more resistant to medical therapy and vitreo-retinal surgery with membrane dissec-
tion is indicated. Intraoperative OCT is an important decision-making tool assisting the surgeon 
to identify the surgical planes and define the relationships of the membrane with the retina [9].
Not only does OCT identify the causes of DME, but it also allows early diagnosis and treat-
ment of DME, before it is clinically significant [10]. This is translated in the clinical practice by 
better anatomical and functional outcomes.
The moment of treatment emerges from the OCT aspect correlated with visual acuity. 
Generally, there is a parallel correspondence between the anatomical and functional data. 
However, if OCT shows a slight increase in central retinal thickness (CRT) but visual acuity is 
20/20, the patient is watched closely, and treatment is promptly initiated if the visual function 
follows a negative trend [10].
Usually, the evolution of OCT aspect of the macula is parallel to the response of visual acuity. If 
the increase of visual acuity does not correspond to the improvement of OCT aspect, a long time 
evolution of DME and/or the use of multiple treatment modalities should be considered [10].
9. Conclusions
OCT is a noninvasive, well-tolerated method, easy to understand and explain. It offers quali-
tative information on retinal thickness, and it is reliable and reproducible. OCT reveals the 
presence and extension of vitreo-macular traction.
There is a correlation between macular thickness and visual acuity in patients with DME. The 
OCT pattern that was associated with worse visual outcome is CME.
In DME OCT technology has significant impact at various levels: it elucidates the pathogenic 
mechanisms of DME; it has a major contribution in identifying hyaloid-macular traction; 
it identifies the subclinical DME allowing early treatment; it makes it possible to correlate 
macular thickness with visual acuity; it monitors the evolution of DME following treatment.
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